Analysis of protection afforded by a Clostridium perfringens alpha-toxoid against heterologous clostridial phospholipases C

Microb Pathog. 2007 Oct;43(4):161-5. doi: 10.1016/j.micpath.2007.05.004. Epub 2007 May 18.

Abstract

The major virulence determinant in clostridial myonecrosis caused by Clostridium perfringens is a phospholipase C (PLC), the alpha-toxin. Previously, mice have been protected against challenge with heterologous alpha-toxin or Clostridium perfringens spores by immunisation with the C-domain (known as Cpa(247-370) or alpha-toxoid) of the alpha-toxin. In this study, we have determined the ability of the alpha-toxoid to protect against the lethal effects of a divergent C. perfringens alpha-toxin and against the PLCs of C. absonum or C. bifermentans, species which have been isolated from cases of clostridial myonecrosis. Protection against the C. perfringens alpha-toxin variant, the C. absonum alpha-toxin or the C. bifermentans PLC was elicited by immunisation with the alpha-toxoid in vivo.

MeSH terms

  • Animals
  • Bacterial Toxins / immunology*
  • Bacterial Vaccines / immunology
  • Bacterial Vaccines / pharmacology*
  • Calcium-Binding Proteins / immunology*
  • Cattle
  • Clostridium Infections / enzymology
  • Clostridium Infections / immunology
  • Clostridium Infections / microbiology
  • Clostridium Infections / prevention & control*
  • Clostridium bifermentans / enzymology*
  • Clostridium perfringens / immunology*
  • Cross Reactions
  • Female
  • Mice
  • Mice, Inbred BALB C
  • Recombinant Proteins / biosynthesis
  • Recombinant Proteins / genetics
  • Recombinant Proteins / isolation & purification
  • Recombinant Proteins / pharmacology
  • Type C Phospholipases / antagonists & inhibitors*
  • Type C Phospholipases / immunology
  • Type C Phospholipases / metabolism

Substances

  • Bacterial Toxins
  • Bacterial Vaccines
  • Calcium-Binding Proteins
  • Recombinant Proteins
  • Type C Phospholipases
  • alpha toxin, Clostridium perfringens